PSquared Asset Management’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
PSquared Asset Management's RNAM Position: Q1 2026 in Review
PSquared Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 168,415 shares — an estimated $12.1M sold.
PSquared Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- PSquared Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- PSquared Asset Management sold 168,415 Avidity Biosciences shares in Q1 2026, an estimated $12.1M.
- PSquared Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- PSquared Asset Management's Avidity Biosciences position peaked at $12.1M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on PSquared Asset Management's 13F filing for Q1 2026, filed 14 May 2026.